reference/4619517

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4619517

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	813
issn	1558-8238 0021-9738
issueIdentifier	3
pageRange	801-813
publicationName	The Journal of clinical investigation
startingPage	801
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d29184df8844e34b460482b1b6dbad96
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1844b48d91381a4146da0b027e83048d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8fd792bb96217094d7597db224a8f78c
bibliographicCitation	Berlato C, Khan MN, Schioppa T, Thompson R, Maniati E, Montfort A, Jangani M, Canosa M, Kulbe H, Hagemann UB, Duncan AR, Fletcher L, Wilkinson RW, Powles T, Quezada SA, Balkwill FR. A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer. J Clin Invest. 2017 Mar 01;127(3):801–13. PMID: 28134623; PMCID: PMC5330727.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29a720cd55bb8abc0ca35b3f41d59ff6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c16f153df9342de8a965b633a1d2a186 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30c60a129a8e0f80abfabeffbc8110fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3285d001c36eae0a541b3abb51bbf58c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff2c90a4131fdd1ea3a65d8ce6cdc8c3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_402a2e7b1cf4ff9ca40fbd236ccad155 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b38f6a04f8ea8125b62c0ac9c370e99f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0f6c6f85f96624c412e40c67800c6e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2926-4902 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78c472e2ffb69e18f1a81a68d1e7af21 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b49932a51271d0a1c696f1a066064ac6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_137c48159a5d61d5ee7e29cac7dd25c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6303-6065 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1cc1211a0a42504feec9fcbaaa985295 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8cfbfec2353921172593a73e3115d25 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_28156fef19c90de064b80d34c78aa5eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c74ce727bd4bfe8a3cd64253491de01 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_200b94f691a9c1683c4c319bd5578ccf
date	2017-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC5330727 https://doi.org/10.1172/jci82976 https://pubmed.ncbi.nlm.nih.gov/28134623
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4632 https://portal.issn.org/resource/ISSN/0021-9738 https://portal.issn.org/resource/ISSN/1558-8238
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer
discusses	http://id.nlm.nih.gov/mesh/M000622951 http://id.nlm.nih.gov/mesh/M0276887 http://id.nlm.nih.gov/mesh/M0277062 http://id.nlm.nih.gov/mesh/M0476214 http://id.nlm.nih.gov/mesh/M0250614 http://id.nlm.nih.gov/mesh/M0001358 http://id.nlm.nih.gov/mesh/M0575201 http://id.nlm.nih.gov/mesh/M0504713 http://id.nlm.nih.gov/mesh/M0014578 http://id.nlm.nih.gov/mesh/M0504587 http://id.nlm.nih.gov/mesh/M0011490
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D054398Q000037 http://id.nlm.nih.gov/mesh/D018417Q000276 http://id.nlm.nih.gov/mesh/D009374Q000276 http://id.nlm.nih.gov/mesh/D059016Q000276 http://id.nlm.nih.gov/mesh/D009363Q000037 http://id.nlm.nih.gov/mesh/D007694Q000276 http://id.nlm.nih.gov/mesh/D002292Q000276 http://id.nlm.nih.gov/mesh/D000912Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D002292Q000188 http://id.nlm.nih.gov/mesh/D007371Q000276 http://id.nlm.nih.gov/mesh/D059016Q000235 http://id.nlm.nih.gov/mesh/D000912Q000276 http://id.nlm.nih.gov/mesh/D009374Q000235 http://id.nlm.nih.gov/mesh/D009363Q000276 http://id.nlm.nih.gov/mesh/D054414Q000494 http://id.nlm.nih.gov/mesh/D054398Q000235 http://id.nlm.nih.gov/mesh/D009363Q000235 http://id.nlm.nih.gov/mesh/D054414Q000235 http://id.nlm.nih.gov/mesh/D054414Q000276 http://id.nlm.nih.gov/mesh/D054398Q000276 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D007371Q000235 http://id.nlm.nih.gov/mesh/D002292Q000235 http://id.nlm.nih.gov/mesh/D007680 http://id.nlm.nih.gov/mesh/D009374Q000188 http://id.nlm.nih.gov/mesh/D059016Q000187
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fffbcbd5b830d7b2534c5bdd67ca94f8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8237 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_acabf422d74548f181f8271b71c43cd3

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12773 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1233

Total number of triples: 91.